$0.1776
At close: May 14, 4:00 PM EST
Sangamo Therapeutics Inc
SGMOOTC
The average analyst price target for Sangamo Therapeutics Inc is $4.71, 6264.9% above the current price. Of 4 analysts, 3 rate it Buy and 1 Hold. Targets range from $1 to $10. The latest change came on Nov 7, 2025, when Barclays downgraded Sangamo Therapeutics Inc from Overweight to Equal-Weight and moved its price target from $5 to $1.
Price Target Range — 9 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
